Your browser doesn't support javascript.
loading
Diagnostics in Waldenström's macroglobulinemia: a consensus statement of the European Consortium for Waldenström's Macroglobulinemia.
Dogliotti, Irene; Jiménez, Cristina; Varettoni, Marzia; Talaulikar, Dipti; Bagratuni, Tina; Ferrante, Martina; Pérez, José; Drandi, Daniela; Puig, Noemí; Gilestro, Milena; García-Álvarez, María; Owen, Roger; Jurczak, Wojciech; Tedeschi, Alessandra; Leblond, Veronique; Kastritis, Efstathios; Kersten, Marie José; D'Sa, Shirley; Kascák, Michal; Willenbacher, Wolfgang; Roccaro, Aldo M; Poulain, Stephanie; Morel, Pierre; Kyriakou, Charalampia; Fend, Falko; Vos, Josephine M I; Dimopoulos, Meletios A; Buske, Christian; Ferrero, Simone; García-Sanz, Ramón.
Afiliação
  • Dogliotti I; Unit of Hematology, Department of Biotechnology and Health Sciences, University of Torino, Torino, Italy.
  • Jiménez C; Hematology Department, University Hospital of Salamanca, Research Biomedical Institute of Salamanca (IBSAL), CIBERONC and Center for Cancer Research-IBMCC (University of Salamanca-CSIC), Salamanca, Spain. jscris@usal.es.
  • Varettoni M; Division of Hematology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
  • Talaulikar D; Canberra Health Services, College of Medicine, Biology and Environment Australian National University, Canberra ACT, Australia.
  • Bagratuni T; Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.
  • Ferrante M; Unit of Hematology, Department of Biotechnology and Health Sciences, University of Torino, Torino, Italy.
  • Pérez J; Hematology Department, University Hospital of Salamanca, Research Biomedical Institute of Salamanca (IBSAL), CIBERONC and Center for Cancer Research-IBMCC (University of Salamanca-CSIC), Salamanca, Spain.
  • Drandi D; Unit of Hematology, Department of Biotechnology and Health Sciences, University of Torino, Torino, Italy.
  • Puig N; Hematology Department, University Hospital of Salamanca, Research Biomedical Institute of Salamanca (IBSAL), CIBERONC and Center for Cancer Research-IBMCC (University of Salamanca-CSIC), Salamanca, Spain.
  • Gilestro M; Unit of Hematology, Department of Biotechnology and Health Sciences, University of Torino, Torino, Italy.
  • García-Álvarez M; Hematology Department, University Hospital of Salamanca, Research Biomedical Institute of Salamanca (IBSAL), CIBERONC and Center for Cancer Research-IBMCC (University of Salamanca-CSIC), Salamanca, Spain.
  • Owen R; The Leeds Teaching Hospitals National Health Service Trust, Leeds, UK.
  • Jurczak W; Maria Sklodowska-Curie National Research Institute of Oncology, Krakow, Poland.
  • Tedeschi A; ASST Grande Ospedale Metropolitano Niguarda Hospital, Milan, Italy.
  • Leblond V; Département d'Hématologie Hôpital Pitié-Salpêtrière APHP, UPMC Université Paris, Paris, France.
  • Kastritis E; Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.
  • Kersten MJ; National and Kapodistrian University of Athens School of Medicine, Athens, Greece.
  • D'Sa S; Department of Hematology, Amsterdam UMC, Location University of Amsterdam, Cancer Center Amsterdam and LYMMCARE (Lymphoma and Myeloma Center Amsterdam), Amsterdam, The Netherlands.
  • Kascák M; Centre for Waldenströms Macroglobulinaemia and Related Conditions, University College London Hospitals National Health Service Foundation Trust, London, UK.
  • Willenbacher W; Department of Haematooncology, University Hospital Ostrava and Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic.
  • Roccaro AM; Department of Haematology and Oncology, Internal Medicine V, Innsbruck University Hospital & Syndena GmbH, Connect to Cure, Innsbruck, Austria.
  • Poulain S; Clinical Research Development and Phase I Unit, ASST Spedali Civili di Brescia, Brescia, Italy.
  • Morel P; Laboratory of Hematology, Biology and Pathology Center, CHU of Lille, INSERM UMR-S 1277, Team 4, Oncolille, Lille, France.
  • Kyriakou C; Service d'Hematologie Clinique et Therapie Cellulaire, Centre Hospitalier Universitaire d'Amiens-Picardie, Amiens, France.
  • Fend F; Centre for Waldenströms Macroglobulinaemia and Related Conditions, University College London Hospitals National Health Service Foundation Trust, London, UK.
  • Vos JMI; Institute of Pathology and Comprehensive Cancer Centre, Eberhard-Karls-University, University Hospital Tübingen, Tübingen, Germany.
  • Dimopoulos MA; Department of Hematology, Amsterdam UMC, Location University of Amsterdam, Cancer Center Amsterdam and LYMMCARE (Lymphoma and Myeloma Center Amsterdam), Amsterdam, The Netherlands.
  • Buske C; Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.
  • Ferrero S; National and Kapodistrian University of Athens School of Medicine, Athens, Greece.
  • García-Sanz R; Institute of Experimental Cancer Research, Comprehensive Cancer Center Ulm, University Hospital of Ulm, Ulm, Germany.
Leukemia ; 37(2): 388-395, 2023 02.
Article em En | MEDLINE | ID: mdl-36435884
ABSTRACT
The diagnosis of Waldenström's macroglobulinemia (WM), an IgM-associated lymphoplasmacytic lymphoma, can be challenging due to the different forms of disease presentation. Furthermore, in recent years, WM has witnessed remarkable progress on the diagnostic front, as well as a deeper understanding of the disease biology, which has affected clinical practice. This, together with the increasing variety of tools and techniques available, makes it necessary to have a practical guidance for clinicians to perform the initial evaluation of patients with WM. In this paper, we present the consensus recommendations and laboratory requirements for the diagnosis of WM developed by the European Consortium of Waldenström's Macroglobulinemia (ECWM), for both clinical practice as well as the research/academical setting. We provide the procedures for multiparametric flow cytometry, fluorescence in situ hybridization and molecular tests, and with this offer guidance for a standardized diagnostic work-up and methodological workflow of patients with IgM monoclonal gammopathy of uncertain significance, asymptomatic and symptomatic WM.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Macroglobulinemia de Waldenstrom Tipo de estudo: Diagnostic_studies / Guideline Limite: Humans Idioma: En Revista: Leukemia Assunto da revista: HEMATOLOGIA / NEOPLASIAS Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Itália

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Macroglobulinemia de Waldenstrom Tipo de estudo: Diagnostic_studies / Guideline Limite: Humans Idioma: En Revista: Leukemia Assunto da revista: HEMATOLOGIA / NEOPLASIAS Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Itália